title: Translational Research Working Group developmental pathway for biospecimen-based assessment modalities.
abstract: The Translational Research Working Group (TRWG) was created as a national initiative to evaluate the current status of National Cancer Institute's investment in translational research and envision its future. The TRWG conceptualized translational research as a set of six developmental processes or pathways focused on various clinical goals. One of those pathways describes the development of biospecimen-based assays that use biomarkers for the detection, diagnosis, and prognosis of cancer and the assessment of response to cancer treatment. The biospecimen-based assessment modality pathway was conceived not as comprehensive description of the corresponding real-world processes but rather as a tool designed to facilitate movement of a candidate assay through the translational process to the point where it can be handed off for definitive clinical testing. This paper introduces the pathway in the context of prior work and discusses key challenges associated with the biomarker development process in light of the pathway.
authors.affiliation: Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland, USA. ehawk@mdanderson.org
authors.forename: Sudhir
authors.initials: S
authors.lastname: Srivastava
authors.forename: Joe W
authors.initials: JW
authors.lastname: Gray
authors.forename: Brian J
authors.initials: BJ
authors.lastname: Reid
authors.forename: Oren
authors.initials: O
authors.lastname: Grad
authors.forename: Addison
authors.initials: A
authors.lastname: Greenwood
authors.forename: Ernest T
authors.initials: ET
authors.lastname: Hawk
mesh_terms: D014408:Biomarkers, Tumor / Q000032:analysis*; D005069:Evaluation Studies as Topic; D033161:Government Regulation; D006801:Humans; D033183:Interdisciplinary Communication; D009316:National Institutes of Health (U.S.); D009369:Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D016730:Program Development; D015203:Reproducibility of Results; D012985:Software Design; D014481:United States
chemical_list: D014408:Biomarkers, Tumor
references.citation: N Engl J Med. 2004 Dec 30;351(27):2817-26
references.pmid: 15591335
references.citation: Expert Rev Mol Diagn. 2003 Jul;3(4):507-19
references.pmid: 12877389
references.citation: J Clin Oncol. 2006 Aug 10;24(23):3726-34
references.pmid: 16720680
references.citation: Chromosoma. 1988;97(1):1-5
references.pmid: 3191791
references.citation: Nat Rev Cancer. 2004 Apr;4(4):309-14
references.pmid: 15057290
references.citation: Clin Cancer Res. 2008 Sep 15;14(18):5664-71
references.pmid: 18612047
references.citation: J Natl Cancer Inst. 2001 Jul 18;93(14):1054-61
references.pmid: 11459866
references.citation: Nat Rev Cancer. 2005 Feb;5(2):142-9
references.pmid: 15685197
references.citation: J Mol Diagn. 2000 Aug;2(3):116-23
references.pmid: 11229514